Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF (ARCA:THNR) - Stock Price, News & Analysis

THNR Stock Overview

An exchange traded fund launched and managed by Amplify Investments LLC.

THNR fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF
Historical stock prices
Current Share Price	US$27.96
52 Week High	US$28.11
52 Week Low	US$24.92
Beta	0
11 Month Change	7.42%
3 Month Change	10.38%
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	10.10%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	THNR	US Capital Markets	US Market
7D	1.0%	1.7%	0.3%
1Y	n/a	31.5%	22.2%

Return vs Industry: Insufficient data to determine how THNR performed against the US Capital Markets industry.

Return vs Market: Insufficient data to determine how THNR performed against the US Market.

Price Volatility

Is THNR's price volatile compared to industry and market?
THNR volatility
THNR Average Weekly Movement	2.1%
Capital Markets Industry Average Movement	4.0%
Market Average Movement	6.3%
10% most volatile stocks in US Market	15.0%
10% least volatile stocks in US Market	3.1%

Stable Share Price: THNR has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine THNR's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2024	n/a	n/a	amplifyetfs.com/thnr/

Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF is an exchange traded fund launched and managed by Amplify Investments LLC. The fund is co-managed by Penserra Capital Management LLC. It invests in public equity markets of global region.

Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF Fundamentals Summary

How do Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF's earnings and revenue compare to its market cap?
THNR fundamental statistics
Market cap	US$3.89m
Earnings (TTM)	US$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is THNR overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
THNR income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$0
Earnings	US$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did THNR perform over the long term?

See historical performance and comparison